Position effects

Genomic Disorders: The Genomic Basis of Disease

Volumn , Issue , 2006, Pages 357-369

  Stankiewicz, Pawel ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846952251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-039-3_25     Document Type: Chapter

References (122)

1. Muller HJ. Types of visible variations induced by X-rays in Drosophila. J Genet 1930;22:299-334.
2. Allshire RC, Javerzat JP, Redhead NJ, Cranston G. Position effect variegation at fission yeast centromeres. Cell 1994;76L157-169.
3. Cattanach BM. Position effect variegation in the mouse. Genet Res Camb 1974;23:291-306.
4. Festenstein R, Tolaini M, Corbella P, et al. Locus control region function and heterochromatin-induced position effect variegation. Science 1996;271:1123-1125.
5. Milot E, Fraser P, Grosveld F. Position effects and genetic disease. Trends Genet 1996;12:123-126.
6. Elgin SC, Grewal SI. Heterochromatin: silence is golden. Curr Biol 2003;13:R895-R898.
7. Hall IM, Noma K, Grewal SI. RNA interference machinery regulates chromosome dynamics during mitosis and meiosis in fission yeast. Proc Natl Acad Sci USA 2003;100:193-198.
8. Grewal SI, Rice JC. Regulation of heterochromatin by histone methylation and small RNAs. Curr Opin Cell Biol 2004;16:230-238.
9. Pal-Bhadra M, Leibovitch BA, Gandhi SG, et al. Heterochromatic silencing and HP1 localization in Droso-phila are dependent on the RNAi machinery. Science 2004;303:669-672.
10. Lewis EB. The theory and application of a new method of detecting chromosomal rearrangements in Droso-phila melanogaster. Am Nat 1954;88:225-239.
11. Duncan IW. Transvection effects in Drosophila. Annu Rev Genet 2002;36:521-556.
12. Kleinjan D-J, van Heyningen V. Position effect in human genetic disease. Hum Mol Genet 1998;7: 1611-1618.
13. Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005;76:8-32.
14. Belloni E, Muenke M, Roessler E, et al. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 1996;14:353-356.
15. Roessler E, Ward DE, Gaudenz K, et al. Cytogenetic rearrangements involving the loss of the Sonic Hedgehog gene at 7q36 cause holoprosencephaly. Hum Genet 1997;100:172-181.
16. Sharpe J, Lettice L, Hecksher-Sorensen J, Fox M, Hill R, Krumlauf R. Identification of sonic hedgehog as a candidate gene responsible for the polydactylous mouse mutant Sasquatch. Curr Biol 1999;9:97-100.
17. Lettice LA, Heaney SJ, Purdie LA, et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet 2003;12:1725-1735.
18. Lettice LA, Horikoshi T, Heaney SJH, et al. Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci USA 2002;99:7548-7553.
19. Sagai T, Masuya H, Tamura M, et al. Phylogenetic conservation of a limb-specific, cis-acting regulator of Sonic hedgehog (Shh). Mamm Genome 2004;15:23-34.
20. Sagai T, Hosoya M, Mizushina Y, Tamura M, Shiroishi T. Elimination of a long-range cis-regulatory module causes complete loss of limb-specific Shh expression and truncation of the mouse limb. Development 2005;132:797-803.
21. Crisponi L, Uda M, Deiana M, et al. FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics 2004;83:757-764.
22. Betsen D, Raes J, Leroy BP, et al. Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism blepharophimosis syndrome. Am J Hum Genet 2005;77:205-218.
23. Kleinjan DA, Seawright A, Schedl A, Quinlan RA, Danes S, van Heyningen V. Aniridia-associated translo-cations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. Hum Mol Genet 2001;10:2049-2059.
24. Houston CS, Opitz JM, Spranger JW, et al. The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. Am J Med Genet 1983;15: 3-28.
25. Foster JW, Dominguez-Steglich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530.
26. Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994;79:1111-1120.
27. Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet 1995;32:415-420.
28. Meyer J, Südbeck P, Held M, et al. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet 1997;6:91-98.
29. Pfeifer D, Kist R, Dewar K, et al. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 1999;65:111-124.
30. Wunderle VM, Critcher R, Hastie N, Goodfellow PN, Schedl A. Deletion of long-range regulatory elements upstream of SOX9 causes campomelic dysplasia. Proc Natl Acad Sci USA 1998;95:10, 649-10, 654.
31. Erdel M, Lane A.H., Fresser F, Probst P, Utermann G, Scherer G. A new campomelic dysplasia translocation breakpoint maps 400 kb from SOX9. [abstract P0249]. European Society of Human Genetics Munich. Eur J Hum Genet Suppl 2004;12:136.
32. Pop R, Conz C, Lindenberg KS, et al. Screening of the 1 Mb SOX9 5' control region by array CGH identifies a large deletion in a case of campomelic dysplasia with XY sex reversal. J Med Genet 2004;41:e47.
33. Huang B, Wang S, Ning Y, Lamb AN, Bartley J. Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet 1999;87:349-353.
34. Bishop CE, Whitworth DJ, Qin Y, et al. A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet 2000;26:490-494.
35. Qin Y, Kong Lk, Poirier C, Truong C, Overbeek PA, Bishop CE. Long-range activation of Sox9 in Odd Sex (Ods) mice. Hum Mol Genet 2004;13:1213-1218.
36. Bagheri-Fam S, Ferraz C, Demaille J, Scherer G, Pfeifer D. Comparative genomics of the SOX9 region in human and Fugu rubripes: conservation of short regulatory sequence elements within large intergenic regions. Genomics 2001;78:73-82.
37. Hill-Harfe KL, Kaplan L, Stalker H, et al. Acampomelic campomelic dysplasia and a mild skeletal dysplasia associated with chromosome 17 translocations 900-932 kb upstream of SOX9: Implications for campomelic dysplasia diagnosis and SOX9 regulation. Am J Hum Genet 2004;76:663-671.
38. Velagaleti GVN, Bien-Willner GA, Northup JK, et al. Position effects due to chromosome breakpoints mapping ∼ 900 Kb upstream and ∼ 1.3 Mb downstream of SOX9 in two cases with campomelic dysplasia. Am J Hum Genet 2005;76:652-662.
39. Stankiewicz P, Hill-Harfe KL, Velagaleti GVN, et al. Position effects due to four chromosome breakpoints mapping ∼786-809, 899, 900, and 932 kb upstream and one ∼1.3 Mb downstream of SOX9 in patients with campomelic dysplasia. 5th European Cytogenetics Conference. Madrid, Spain. June 4-7, 2005.
40. Jamshidi N, Macciocca I, Dargaville PA, et al. Isolated Robin sequence associated with a balanced t(2;17) chromosomal translocation. J Med Genet 2004;41:e1.
41. Stalker HJ, Zori RT. Variable expression of rib, pectus, and scapular anomalies with Robin-type cleft palate in a 5-generation family: a new syndrome? Am J Med Genet 1997;73:247-250.
42. Stalker HJ, Gray BA, Zori RT. Dominant transmission of a previously unidentified 13/17 translocation in a five-generation family with Robin cleft and other skeletal defects. Am J Med Genet 2001;103:339-341.
43. Kuhn EJ, Geyer PK. Genomic insulators: connecting properties to mechanism. Curr Opin Cell Biol 2003;15:259-265.
44. Yu W, Ginjala V, Pant V, et al. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 2004;36:1105-1110.
45. Recillas-Targa F, Valadez-Graham V, Farrell CM. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 2004;26:796-807.
46. West AG, Gaszner M, Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev 2002;16:271-288.
47. Burgess-Beusse B, Farrell C, Gaszner M, et al. The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci USA 2002;99:16, 433-16, 437.
48. Yusufzai TM, Tagami H, Nakatani Y, Felsenfeld G. CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol Cell 2004;13:291-298.
49. Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G. Science 2001;293:2453-2455.
50. West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G. Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol Cell 2004;16:453-463.
51. Zhou J, Berger SL. Good fences make good neighbors: barrier elements and genomic regulation. Mol Cell 2004;16:500-502.
52. Webber A, Ingram RI, Levorse J, Tilghman SM. Location of enhancers is essential for imprinting of H19 and Igf2. Nature 1998;391:711-715.
53. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000;405:482-485.
54. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000;405:486-489.
55. Reik W, Murrell A. Genomic imprinting. Silence across the border. Nature 2000;405:408-409.
56. Prawitt D, Enklaar T, Gärtner-Rupprecht B, et al. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci USA 2005;102:4085-4090.
57. Filippova GN, Thienes CP, Penn BH, et al. CTCF-binding sites flank CTG/CAG repeats and form a methy-lation-sensitive insulator at the DM1 locus. Nat Genet 2001;28:335-343.
58. Chao W, Huynh KD, Spencer RJ, Davidow LS, Lee JT. CTCF, a candidate trans-acting factor for X-inacti-vation choice. Science 2002;295:345-347.
59. Pugacheva EM, Tiwari VK, Abdullaev Z, et al. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation. Hum Mol Genet 2005;14:953-965.
60. Ohlsson R, Renkawitz R, Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2002;1:520-527.
61. Nobrega MA, Pennacchio LA. Comparative genomic analysis as a tool for biological discovery. J Physiol 2004;55:31-39.
62. Miller W, Makova KD, Nekrutenko A, Hardison RC. Comparative genomics. Annu Rev Genomics Hum Genet 2004;5:15-56.
63. Dermitzakis ET, Reymond A, Lyle R, et al. Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature 2002;420:578-582.
64. Dermitzakis ET, Reymond A, Scamuffa N, et al. Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science 2003;302:1033-1035.
65. Thomas JW, Touchman JW, Blakesley RW, et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 2003;424:788-793.
66. Gaffney DJ, Keightley PD. Unexpected conserved non-coding DNA blocks in mammals. Trends Genet 2004;20:332-337.
67. Glazko GV, Koonin EV, Rogozin IB, Shabalina SA. A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions. Trends Genet 2003;19:119-124.
68. Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 2003;34:157-165.
69. Kleinjan DJ, van Heyningen V. Turned off by RNA. Nat Genet 2003;34:125-126.
70. Kiyosawa H, Yamanaka I, Osato N, Kondo S, Hayashizaki Y. Antisense transcripts with FANTOM2 clone set and their implications for gene regulation. Genome Res 2003;13:1324-1334.
71. Yelin R, Dahary D, Sorek R, et al. Widespread occurrence of antisense transcription in the human genome. Nature Biotechnol 2003;21:379-386.
72. Mattick JS. RNA regulation: a new genetics? Nat Rev Genet 2004;5:316-323.
73. Ptashne M. Gene regulation by proteins acting nearby and at a distance. Nature 1986;322:697-701.
74. Mueller HP, Schaffner W. Transcriptional enhancers can act in trans. Trends Genet 1990;6:300-304.
75. Hanscombe O, Whyatt D, Fraser P, et al. Importance of globin gene order for correct developmental expression. Genes Dev 1991;5:1387-1394.
76. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002;295: 1306-1311.
77. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 2002;10:1453-1465.
78. Palstra R-J, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W. The β-globin nuclear compartment in development and erythroid differentiation. Nat Genet 2003;35:190-194.
79. Patrinos GP, de Krom M, de Boer E, et al. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev 2004;18:1495-1509.
80. Horike S, Cai S, Miyano M, Cheng J-F, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005;37:31-40.
81. Saitoh Y, Laemmli UK. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 1994;76:609-622.
82. Heng HH, Goetze S, Ye CJ, et al. Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci 2004;117:999-1008.
83. Strick R, Laemmli UK. SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein. Cell 1995;83:1137-1148.
84. Ioudinkova E, Petrov A, Razin SV, Vassetzky YS. Mapping long-range chromatin organization within the chicken alpha-globin gene domain using oligonucleotide DNA arrays. Genomics 2005;85:143-151.
85. Valadez-Graham V, Razin SV, Recillas-Targa F. CTCF-dependent enhancer blockers at the upstream region of the chicken alpha-globin gene domain. Nucleic Acids Res 2004;32:1354-1362.
86. Cremer T, Kupper K, Dietzel S, Fakan S. Higher order chromatin architecture in the cell nucleus: on the way from structure to function. Biol Cell 2004;96:555-567.
87. Verschure PJ, van Der Kraan I, Manders EM, van Driel R. Spatial relationship between transcription sites and chromosome territories. J Cell Biol 1999;147:13-24.
88. Spector DL. The dynamics of chromosome organization and gene regulation. Annu Rev Biochem 2003;72:573-608.
89. Tanabe H, Müller S, Neusser M, et al. Evolutionary conservation of chromosome territory arrangements in cell nuclei from higher primates. Proc Natl Acad Sci USA 2002;99:4424-4429.
90. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 2004;118:555-666.
91. Bickmore WA, van der Maarel SM. Perturbations of chromatin structure in human genetic disease: recent advances. Hum Mol Genet 2003;12:R207-R213.
92. Cho KS, Elizondo LI, Boerkoel CF. Advances in chromatin remodeling and human disease. Curr Opin Genet Dev 2004;14:308-315.
93. Mounkes L, Kozlov S, Burke B, Stewart CL. The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev 2003;13:223-230.
94. Maraldi NM, Squarzoni S, Sabatelli P, et al. Laminopathies: involvement of structural nuclear proteins in the pathogenesis of an increasing number of human diseases. J Cell Physiol 2004;203:319-327.
95. Gabellini D, Tupler R, Green MR. Transcriptional derepression as a cause of genetic diseases. Curr Opin Genet Dev 2003;13:239-245.
96. Gabellini D, Green MR, Tupler R. When enough is enough: genetic diseases associated with transcriptional derepression. Curr Opin Genet Dev 2004;14:301-307.
97. van Overveld PG, Lemmers RJ, Sandkuijl LA, et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003;35:315-317.
98. Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002;110:339-348.
99. Jiang G, Yang F, Van Overveld PG, Vedanarayanan V, van der MS, Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003;12:2909-2921.
100. Tupler R, Gabellini D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci 2004;61:557-566.
101. van der Maarel SM, Frants RR. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. Am J Hum Genet 2005;76:375-386.
102. Hewitt JE, Lyle R, Clark LN, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3:1287-1295.
103. Winokur ST, Bengtsson U, Feddersen J, et al. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994;2:225-234.
104. van Deutekom JCT. Towards the molecular mechanism of facioscapulohumeral muscular dystrophy. PhD thesis, Leiden University, Leiden, 1996.
105. Masny PS, Bengtsson U, Chung SA, et al. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum Mol Genet 2004;13:1857-1871.
106. Tam R, Smith KP, Lawrence JB. The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. J Cell Biol 2004;167:269-279.
107. Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P. Long-range chromatin regulatory interactions in vivo. Nat Genet 2002;32:623-626.
108. Vakoc CR, Letting DL, Gheldof N, et al. Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol Cell 2005;17:453-462.
109. Drissen R, Palstra RJ, Gillemans N, et al. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev 2004;18:2485-2490.
110. Osborne CS, Chakalova L, Brown KE, et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 2004;36:1065-1071.
111. Carter NP, Vetrie D. Applications of genomic microarrays to explore human chromosome structure and function. Hum Mol Genet 2004;13:R297-R302.
112. Bussiek M, Toth K, Brun N, Langowski J. DNA-loop formation on nucleosomes shown by in situ scanning force microscopy of supercoiled DNA. Mol Biol 2005;345:695-706.
113. Cmarko D, Verschure PJ, Otte AP, van Driel R, Fakan S. Polycomb group gene silencing proteins are concentrated in the perichromatin compartment of the mammalian nucleus. J Cell Sci 2003;116:335-343.
114. McArthur M, Gerum S, Stamatoyannopoulos G. Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR. J Mol Biol 2001;313:27-34.
115. de Kok YJM, Vossenaar ER, Cremers CWRJ, et al. Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet 1996;5:1229-1235.
116. Davies AF, Mirza G, Flinter F, Ragoussis J. An interstitial deletion of 6p24-p25 proximal to the FKHL7 locus and including AP-2alpha that affects anterior eye chamber development. J Med Genet 1999;36:708-710.
117. Jamieson RV, Perveen R, Kerr B, et al. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum Mol Genet 2002;11:33-42.
118. Kimura-Yoshida C, Kitajima K, Oda-Ishii I, et al. Characterization of the pufferfish Otx2 cis-regulators reveals evolutionarily conserved genetic mechanisms for vertebrate head specification. Development 2004;131:57-71.
119. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. Scanning human gene deserts for long-range enhancers. Science 2003;302:413.
120. Lee JA, Madrid RE, Sperle K, Ritterson C, Hobson GM, Garbern J, Lupski JR, Inoue K. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 2005;in press.
121. Muncke N, Wogatzky BS, Breuning M, et al. Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms. J Med Genet 2004;41:e121.
122. Shen JJ, Kurotaki N, Patel A, Lupski JR, Brown CW. Low factor XII level in an individual with Sotos syndrome. Pediatr Blood Cancer 2005;44:187-189.